Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
| Image |  |
|---|---|
| Description | scientific article published on 22 December 2014 |
| Author/s |
author: Stefan W. Krause German Hodgkin Study Group Josée M. Zijlstra |
| Publication date | December 22, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |